The overlap of atopy and functional gastrointestinal disorders among 23 471 patients in primary care

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 4, 2014, Pages 382-391

  Jones, M P ^a   Walker, M M ^b   Ford, A C ^c,d   Talley, N J ^b  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ANXIETY DISORDER; ARTICLE; ASTHMA; ATOPY; COMORBIDITY; CONJUNCTIVITIS; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DYSPEPSIA; ECZEMA; FEMALE; HAY FEVER; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CONSTIPATION; DYSPEPSIA; FEMALE; HUMANS; HYPERSENSITIVITY; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84904460081     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12846     Document Type: Article

References (48)

1. Choy EHS, Panayi GS,. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-16.
2. Gisondi P, Girolomoni G,. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 2009; 35: 313-24.
3. Bousquet J, Chanez P, Lacoste JY, et al,. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-9.
4. Chan LS, Robinson N, Xu L,. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic. Dermatitis 2001; 117: 977-83.
5. Walker MM, Powell N, Talley NJ,. Atopy and the gastrointestinal tract-a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol 2014; 8: 289-99.
6. Collins SM, Piche T, Rampal P,. The putative role of inflammation in the irritable bowel syndrome. Gut 2001; 49: 743-5.
7. Walker MM, Talley NJ, Prabhakar M, et al,. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009; 29: 765-73.
8. Ford AC, Talley NJ,. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol 2011; 46: 421-31.
9. Walker MM, Salehian SS, Murray CE, et al,. Implications of eosinophilia in the normal duodenal biopsy-an association with allergy and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 1229-36.
10. Kindt S, Van Oudenhove L, Broekaert D, et al,. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21: 389-98.
11. Powell N, Huntley B, Beech T, Knight W, Knight H, Corrigan CJ,. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J 2007; 83: 182-6.
12. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA,. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci 2007; 52: 329-35.
13. Huerta C, Garcia Rodriguez LA, Wallander MA, Johansson S,. Risk of irritable bowel syndrome among asthma patients. Pharmacoepidemiol Drug Saf 2002; 11: 31-5.
14. Panicker R, Arifhodzic N, Al Ahmad M, Ali SA,. Association and symptom characteristics of irritable bowel syndrome among bronchial asthma patients in Kuwait. Ann Thorac Med 2010; 5: 37-42.
15. Hunskar GS, Langeland N, Wensaas KA, et al,. The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study. Scand J Gastroenterol 2012; 47: 956-61.
16. Zuo XL, Li YQ, Li WJ, et al,. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clin Exp Allergy 2007; 37: 823-30.
17. Chin KC, Tarlow MJ, Allfree AJ,. Allergy to cows' milk presenting as chronic constipation. BMJ 1983; 287: 1593.
18. Dehghani SM, Ahmadpour B, Haghighat M, Kashef S, Imanieh MH, Soleimani M,. The role of cow's milk allergy in pediatric chronic constipation: a randomized clinical trial. Iran J Pediatr 2012; 22: 468-74.
19. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ,. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61: 1284-90.
20. Lovell RM, Ford AC,. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 991-1000.
21. Blak BT, Thompson M, Dattani H, Bourke A,. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011; 19: 251-5.
22. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL,. Validation studies of the health improvement network (THIN) database for pharmacoepidemio-logy research. Pharmacoepidemiol Drug Saf 2007; 16: 393-401.
23. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ,. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69: 4-14.
24. Chisholm J,. The read clinical classification. BMJ 1990; 300: 1092.
25. Britain JFCotBMAaTPSoG. British National Formulary. London: BMJ Publishing Group Ltd and Royal Pharmaceutical Society, 2013.
26. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
27. Gladman LM, Gorard DA,. General practitioner and hospital specialist attitudes to functional gastrointestinal disorders. Aliment Pharmacol Ther 2003; 17: 651-4.
28. Engsbro AL, Begtrup LM, Kjeldsen J, et al,. Patients suspected of irritable bowel syndrome-cross-sectional study exploring the sensitivity of Rome III criteria in primary care. Am J Gastroenterol 2013; 108: 972-80.
29. Cash BD, Schoenfeld P, Chey WD,. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812-9.
30. Agreus L, Svardsudd K, Nyren O, Tibblin G,. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol 1994; 29: 102-9.
31. Drossman DA, Li Z, Andruzzi E, et al,. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
32. Nakajima S, Takahashi K, Sato J, et al,. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping. J Gastroenterol Hepatol 2010; 25 (Suppl. 1): S138-43.
33. Powell N, Huntley B, Beech T, Knight W,. Upper gastrointestinal symptoms and asthma: a manifestation of allergy? Gut 2008; 57: 1026-7.
34. Lydiard RB,. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 2001; 62 (Suppl. 8): 38-45; discussion 6-7.
35. Fang BJ, Tonelli LH, Soriano JJ, Postolache TT,. Disturbed sleep: linking allergic rhinitis, mood and suicidal behavior. Front Biosci (Schol Ed) 2010; 2: 30-46.
36. Teufel M, Biedermann T, Rapps N, et al,. Psychological burden of food allergy. World J Gastroenterol 2007; 13: 3456-65.
37. Camilleri M, Carlson P, McKinzie S, et al,. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil 2011; 23: 935-e398.
38. Talley NJ, Walker MM, Aro P, et al,. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007; 5: 1175-83.
39. Walker MM, Warwick A, Ung C, Talley NJ,. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep 2011; 13: 323-30.
40. Hansel TT, Johnston SL, Openshaw PJ,. Microbes and mucosal immune responses in asthma. Lancet 2013; 381: 861-73.
41. Sarna S,. Lessons learnt from post-infectious IBS. Front Physiol 2011; 2: 49.
42. Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J,. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009; 21: 832-e56.
43. Ford AC, Thabane M, Collins SM, et al,. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology 2010; 138: 1727-36 quiz e12.
44. Liezmann C, Klapp B, Peters EM,. Stress, atopy and allergy: a re-evaluation from a psychoneuroimmunologic persepective. Dermatoendocrinology 2011; 3: 37-40.
45. Andreasson AN, Jones MP, Walker MM, Talley NJ, Nyhlin H, Agréus L,. 158. Prediction pathways for innate immune pathology, IBS, anxiety and depression in a general population (the PopCol study). Brain Behav Immun 2013; 32: e46.
46. Liebregts T, Adam B, Bredack C, et al,. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-20.
47. Eyerich K, Novak N,. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013; 68: 974-82.
48. Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A,. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008; 100: 49-53.